Guardian Pharmacy Services (NYSE:GRDN) Rating Lowered to "Hold" at Wall Street Zen

Key Points

• Wall Street Zen downgraded Guardian Pharmacy Services from “Buy” to “Hold,” though the broader analyst consensus remains “Moderate Buy,” with eight Buy ratings and one Hold rating.
• Other analysts have raised their price targets, with the consensus target at $43.83 versus the stock’s reported opening price of $45.02 and 52-week high of $48.33.
• Guardian exceeded quarterly expectations, reporting $0.29 in EPS on $351.77 million in revenue, beating estimates of $0.26 EPS and $340.45 million in revenue; several institutional investors also increased or initiated positions.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

A number of other brokerages have also recently commented on GRDN. Oppenheimer upped their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, August 20th. Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a "buy" rating in a report on Wednesday, June 17th. Finally, Bank of America boosted their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a "buy" rating in a research note on Wednesday, June 17th. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Guardian Pharmacy Services currently has an average rating of "Moderate Buy" and a consensus price target of $43.83.

Guardian Pharmacy Services Price Performance

NYSE:GRDN opened at $45.02 on Friday. The business has a fifty day simple moving average of $40.48 and a two-hundred day simple moving average of $38.88. Guardian Pharmacy Services has a 1 year low of $23.14 and a 1 year high of $48.33. The company has a market capitalization of $2.24 billion, a P/E ratio of 43.71, a P/E/G ratio of 2.33 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.03. The firm had revenue of $351.77 million for the quarter, compared to analysts' expectations of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. As a group, analysts anticipate that Guardian Pharmacy Services will post 1.19 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Arizona State Retirement System grew its position in shares of Guardian Pharmacy Services by 53.0% during the 2nd quarter. Arizona State Retirement System now owns 8,393 shares of the company's stock valued at $351,000 after purchasing an additional 2,907 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Guardian Pharmacy Services during the second quarter valued at $335,000. Round Rock Advisors LLC boosted its stake in Guardian Pharmacy Services by 57.0% during the second quarter. Round Rock Advisors LLC now owns 18,524 shares of the company's stock valued at $776,000 after buying an additional 6,729 shares during the period. Braun Stacey Associates Inc. purchased a new position in Guardian Pharmacy Services during the second quarter worth about $14,234,000. Finally, Ranger Investment Management L.P. purchased a new position in Guardian Pharmacy Services during the second quarter worth about $7,263,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company's services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.